Aims: We assessed gender differences in pre-event health status (symptoms, functioning, quality of life) in young patients with acute myocardial infarction and whether or not this association persists following sequential adjustment for important covariates. We also evaluated the interaction between gender and prior coronary artery disease, given that aggressive symptom control is a cornerstone of care in those with known coronary disease. Methods and results: A total of 3501 acute myocardial infarction patients (2349 women) aged 18-55 years were enrolled from 103 US/24 Spanish hospitals (2008)(2009)(2010)(2011)(2012). Clinical/health status information was obtained by medical record abstraction and patient interviews. Pre-event health status was measured by generic (Short Form-12, EuroQoL) and disease-specific (Seattle Angina Questionnaire) measures. T-test/chi-square and multivariable linear/logistic regression analysis was utilized, sequentially adjusting for covariates. Women had more co-morbidities and significantly lower generic mean health scores than men (Short Form-12 physical health = 43±12 vs. 46±11 and mental health = 44±13 vs. 48±11); EuroQoL utility index = 0.7±0.2 vs. 0.8±0.2 and visual analog scale = 63±22 vs. 67±20, P < 0.0001 for all. Their disease-specific health status was also worse, with more angina (Seattle Angina Questionnaire angina frequency = 83±22 vs. 87±18), worse physical function (physical limitation = 78±27 vs. 87±21) and poorer quality of life (55±25 vs. 60±22, P<0.0001 for all). In multivariable analysis, the association between female gender and worse generic physical/mental health persisted, as well as worse disease-specific physical limitation and quality of life. The interaction between gender and prior coronary artery disease was not significant in any of the health status outcomes. Conclusion: Young women have worse pre-event health status as compared with men, regardless of their coronary artery disease history. While future studies of gender differences should adjust for baseline health status, an opportunity may exist to better address the pre-event health status of women at risk for acute myocardial infarction.
Introduction
Young women (⩽55 years) have a 2-3-fold greater in-hospital mortality following acute myocardial infarction (AMI) as compared with young men. 1, 2 Because health status has been shown to predict short and long-term adverse cardiovascular events, 3, 4 it is possible that earlier recognition of patients' compromised health status could create opportunities to organize more aggressive treatment and intensify preventive strategies. Beyond its prognostic importance, patient-reported health status measures are increasingly used to quantify patients' perceptions of how their disease affects them in terms of their symptoms, function and quality of life 5 and have been advocated as a marker of healthcare quality. 4, 6 Patients' health status is not only an important outcome, 7 but can be used clinically to optimize treatment in stable coronary artery disease (CAD). Importantly, while an AMI represents a critical clinical event for CAD patients, it is often preceded by worsening symptoms and health status. Despite the high rates of morbidity and mortality outcomes for young women with an AMI, 1, 2 no prior study has explored whether or not their pre-admission health status is worse than that of men. Understanding the profiles of young women with an AMI is an important first step in tailoring therapy to these patients and improving their outcomes. To address this gap in knowledge, we sought to: (a) assess gender differences in pre-event patient-reported health status (including angina symptoms, quality of life, general physical/mental functioning); (b) investigate whether any gender differences in pre-event health status persist after sequential adjustment for important covariates; (c) evaluate the interaction between gender and prior CAD given that, among those with known CAD, aggressive treatment of symptoms is a standard of care. Based on previous research, [8] [9] [10] we hypothesized that young women with AMI would have increased angina, more physical limitations, poorer disease-specific quality of life and worse physical/mental functioning, measured at the time of their AMI, as compared with men. Between HL081153-05). The study was designed to investigate factors associated with higher mortality in young women with AMI. 11 Patients were prospectively recruited and enrolled in the VIRGO study, which used a 2:1 female to male enrollment design to enrich the study's inclusion of young women. Every attempt was made to enroll consecutive young women with an AMI at each center. After two women were recruited, the next young man with an AMI was recruited at each site. A total of 5585 patients with AMI were screened at participating sites, of which 3572 were eligible and enrolled. The final cohort used in this study consisted of 2985 from the US (2009 women, 976 men), and 516 patients from Spain (340 women, 176 men), with a total of 3501 patients (N=2349 women; N=1152 men).
Methods

Study sample
Participants
The VIRGO methodology and design have been previously described. 11 In brief, participants were 18-55 years old and AMI was confirmed by increased cardiac biomarkers within 24 hours of admission and at least either ischemic symptoms or electrocardiographic changes. Participants must have presented directly to the enrolling site or been transferred within 24 hours of presentation, thus ensuring that primary clinical decision-making occurred at the enrolling site. Exclusion criteria included: (a) non-English/ non-Spanish speaking patients; (b) inability to provide informed consent; (c) incarceration; (d) those patients who developed elevated cardiac markers as a result of elective coronary revascularization. Institutional Review Board approval was obtained at each participating institution and patients provided informed consent for their study participation including baseline and follow-up interviews.
Socio-demographics and clinical variables
Baseline data (i.e. index AMI admission) were collected by medical chart abstraction and standardized in-person interviews during the index AMI admission by trained personnel. 11 The patient domains collected include detailed information on socio-demographics, socio-economic status (SES), cardiovascular risk factors, prior co-morbidities and chronic risk factors (Table 1 , Appendix 1).
Health status measures
Both generic (Short Form-12 [SF-12], 12 the EuroQoL Quality of Life Scale [EQ-5D]) 13 and disease-specific health status instruments (Seattle Angina Questionnaire [SAQ 14 ]) were administered at the baseline interview to capture pre-event health status. The SF-12 and SAQ have 4-week recall periods, while the EQ-5D inquires about current health.
SF-12.
The SF-12 has been demonstrated to be a valid and reliable instrument and is widely used to quantify patients' overall mental/physical functional status 12 . The SF-12 physical (PCS) and mental (MCS) component summary scores were calculated and range from 0 to 100, with higher scores indicating higher functioning. A score of 50 represents the US population average, with a standard deviation of 10 points. Additionally, a mean PCS score of 48±10.6 and a MCS score of 53±10.7 represent the population averages for Spain. 15 A mean score of ⩾5-10 for a 0.5-1.0 standard deviation change is considered clinically significant. 16, 17 EQ-5D. The EQ-5D is a standardized measure of generic health status 13 and has previously been validated in AMI patients. 18 This questionnaire has two parts: a descriptive section that classifies patients into one of 243 health states consisting of the following dimensions: mobility; self-care; usual activities; pain/discomfort; anxiety/depression; a 20 cm visual analog scale (EQ-VAS), which ranges from 0 to 100, with higher scores indicating better health states. 19 A mean VAS score ranging from 79 to 86 and 73 to 82 represents the US and Spanish population average for patients between 18-55 years. Similarly, a utility index score ranging from 0.80 to 0.89 and 0.91 to 0.96 represents the US and Spanish population average for patient's 18-55 years. 20 The mean (SD) minimally important difference is 0.040 (0.026), based on the US algorithm. 21, 22 SAQ. The SAQ is a 19-item disease-specific health status measure for patients with CAD, which has demonstrated validity, reliability and clinical responsiveness 14, 23 and is predictive of mortality and re-hospitalization 4 . The five clinically relevant domains of the SAQ include physical limitation, angina stability, angina frequency, treatment satisfaction and quality of life. For the purpose of this study, the physical limitation, angina frequency, treatment satisfaction and quality of life domains were used. Each domain has a range of 0-100 points with higher scores indicating higher levels of functioning. A mean difference of greater than 5 points between groups for all scales is considered clinically significant. 14 
Statistical analysis
Baseline characteristics were examined for the total sample and compared between men and women using Chi-squared tests for categorical variables and t-tests for continuous variables. Baseline health status results (SF-12, EQ-5D, SAQ) are reported as mean and SD. To examine the relationship between gender and health status, as indicated by SAQ physical limitation and angina frequency scores, we used a sequential logistic modeling approach by dichotomizing the physical limitation score into no physical limitations due to angina (SAQ Physical limitation=100) vs. any (SAQ Physical limitation <100) and the angina frequency score into no angina over the past 4 weeks (SAQ Angina frequency=100) vs. any (SAQ Angina frequency<100). The SAQ quality of life scores, SF-12 PCS and MCS were modeled using a sequential linear regression modeling approach. For all models, we sequentially adjusted for potential confounders and, at each step, assessed the association of gender with the outcome. . In these sequential models, interaction terms between gender and country (i.e. US vs. Spain) were also evaluated (Appendix 1).
In addition, we conducted a subgroup analysis of the baseline health status results for men and women with and without prior CAD (defined as prior AMI/ percutaneous coronary intervention/ coronary artery bypass grafting) to explore whether the pre-event health status differed by gender among those with known CAD as compared with a new diagnosis. This analysis permitted an evaluation of patients' symptoms and health status prior to an AMI among those with known CAD in whom optimizing their symptom control is a guideline-endorsed goal. Interaction terms between gender and prior CAD were evaluated for the SAQ physical limitation, angina frequency and quality of life scores as well as the SF-12 PCS and MCS scores. For all analyses, the complete available dataset was used with no imputation for missing variables (for all three health status measures only <5% were missing data on both genders). A p-value < 0.05 was considered statistically significant. All analyses were computed using SAS 9.3 (SAS Institute Inc., Cary, NC).
Results
Baseline characteristics
Baseline characteristics of the total sample (N=3501), stratified by gender (N=2349 67% women) are shown in Table  1 . Both genders were of similar age, but women were more likely to be black, to be single, have health insurance and to be unemployed as compared with men. In addition, women were more likely to have diabetes mellitus, obesity, congestive heart failure, renal dysfunction, chronic lung disease, prior stroke/TIA, autoimmune disorders and depression, but less likely to have dyslipidemia or alcohol abuse.
Health status analyses
The generic and disease-specific health status of women was significantly lower on admission than men ( Table 2) . On presentation, women had significantly poorer physical (PCS [mean±SD] = 43±12 vs. 46±11, P < 0.0001]) and mental (MCS = 44±13 vs. 48±11, P < 0.0001) generic health status than men. In addition, women scored significantly poorer on the EQ-5D index score (0.7±0.2 vs. 0.8±0.2, P < 0.0001) and the EQ-5D VAS (VAS = 63±22 vs. 67±20, P < 0.0001). Women reported more diseasespecific physical limitations (78±27 vs. 87±21, P < 0.0001), more angina frequency (83±22 vs. 87±18, P < 0.0001), less treatment satisfaction (91±14 vs. 93±11, P < 0.0001) and worse quality of life (55±25 vs. 60±22, P < 0.0001) than men. When dichotomizing physical function and symptoms, women were more likely to report having physical limitations due to angina (57% vs. 47% of men; P < 0.0001) and angina (55% of women vs. 50% of men, P = 0.0061) than men prior to their AMI.
Multivariable analyses of gender differences in pre-event health status
In the model only including gender, women were more likely to report physical limitations due to angina, with the odds of having any limitations being 1.52 (95% confidence intervals [CI] 1.32-1.76). After sequentially adjusting for the numerous differences between women and men (Figure 1a ), women were significantly more likely to report physical limitations due to angina prior to their AMI (odds ratio (OR) = 1.30 (95% CI 1.10, 1.53).
Women were also more likely to report having angina prior to their AMI (female OR = 1.22, 95% CI 1.06-1.40). However, after adjusting for socio-demographics, SES, cardiovascular risk factors, prior co-morbidities and chronic risk factors, gender was no longer independently associated with having angina (female OR = 1.07, 95% CI 0.91-1.25) prior to an AMI (Figure 1b ).
Women were also more likely to report a poorer quality of life than men, as per the SAQ quality of life score in unadjusted analyses (β = −5.67±0.86, P < 0.0001). After full adjustment, the effect of gender was attenuated, but still statistically significant (β = −3.19, SE = 0.89, P = 0.0004; (Figure 1c ).
In regard to generic health status, women reported having a poorer PCS in unadjusted analyses (β = −3.39, SE = 0.44, P < 0.0001). Following adjustment for socio-demographics, SES, cardiovascular risk factors, prior co-morbidities and chronic risk factors, the effect of gender was attenuated (β = −1.03, SE = 0.42, P = 0.0136) ( Figure 1d ). Finally, women also reported a poorer MCS in unadjusted analyses (β=-4.53, SE=0.46, P<0.0001), which was also attenuated with full adjustment (β = −2.08, SE = 0.46, P < 0.0001) ( Figure 1e ).
We tested the gender vs. country interaction (US vs. Spain), which was not significant in the SF-12 (PCS, MCS) or the SAQ health status outcomes (physical limitation, angina frequency, quality of life), suggesting that the relationship between health status and gender did not vary by country (Appendix 1).
Pre-event health status of patients with prior CAD/No prior CAD
In patients with known prior CAD before their AMI, women (n = 436) had poorer scores than men on the SF-12 PCS and MCS, indicating poorer physical and mental functioning. In regard to the SAQ domains, women had more physical limitations, more angina, less treatment satisfaction and a poorer quality of life than men (n = 236). Women with prior CAD also reported a poorer EQ-5D index utility score and VAS score (Appendix 2). Similarly, in those patients with no previous CAD, women (n = 1913) again had poorer scores on the SF-12 PCS and MCS, indicating poorer physical and mental functioning. In regard to the SAQ domains, women had more physical limitations, more angina, less treatment satisfaction and a poorer quality of life (Appendix 3). Women with no prior CAD also reported a poorer EQ-5D index utility score and VAS score (Appendix 3). The gender vs. prior CAD interaction was not significant in any of the SF-12 generic health status outcomes or the SAQ health status outcomes, suggesting that the worse health status prior to AMI was present in women, regardless of their CAD history.
Discussion
This is the first study, to our knowledge, to compare the preevent health status of young women (≤55 years), with that of young men. We found that young women not only present with more co-morbidities at initial hospitalization, but also report significantly poorer physical and mental functioning, more symptoms of angina and poorer quality of life in the weeks leading up to their AMI. The poorer health status outcomes persisted even after we considered the <45 and ≥45 cut-off as a surrogate for hormonal status. After adjusting for a myriad of potential confounders, women still had poorer pre-event physical limitations and quality of life, as well as poorer physical/mental functioning compared with men. These associations existed, regardless of country and whether or not patients had known CAD prior to their infarct. The latter findings suggest that the management of patients' health status prior to their AMI differs for men and women and/or that women have the tendency to report lower health status due to other potential mechanisms (i.e. disposition to report worse health states, societal roles/burden, hormonal/genetic explanations). 24, 25 Importantly, health status scores for women and men reached the threshold for what is defined as a clinically relevant difference (i.e. mean difference of >5 points on the SAQ) 14 for the physical limitation, angina frequency and quality of life domains, but not for the treatment satisfaction domain. Similarly, health status scores for both genders reached the threshold for a clinically relevant difference on the SF-12 MCS score but not the PCS. 16, 17, 26 We observed small to medium effect sizes, in all of our multivariable models, which suggest that more effective therapies in those with new or known CAD may alleviate the health status burden of these young patients. In terms of population norms, young women and men with AMI had decreased SF-12 PCS and MCS scores when compared with US and Spanish general population averages. [15] [16] [17] In addition, both genders rated their current health strikingly lower on the EQ-5D VAS score, in comparison to US/Spanish population norms; however, their index scores were similar. 20, 22 These findings extend the existing literature by providing novel insights into gender differences in health status prior to an AMI. [8] [9] [10] [27] [28] [29] [30] Gender differences in patient-centered outcomes, such as angina, disease-specific quality of life and general health status, have rarely been studied in AMI, particularly in a younger cohort of patients (i.e. ≤55 years). Preliminary data have suggested that manifestations of CAD, depression, co-morbidities, infarct severity and baseline health-related quality of life are associated with quality of life after AMI. [31] [32] [33] Although studies have recognized that women have a poorer quality of life as compared with men, [24] [25] [26] [27] [28] [29] [30] [31] 34 particularly in the early recovery period (i.e. 1-12 months post AMI), 9, 29, 34 our results demonstrate that young women report poorer health even before their infarct. From a methodological standpoint, future gender-based comparisons of health status outcomes should adjust for patients' pre-event health status, given its strong association with subsequent health status (i.e. 1-month or 12-month endpoints). 10, 35 The underlying factors contributing to the observed gender disparity in health status at the time of an AMI may include differences in clinical characteristics (i.e. disease severity), 32 psychosocial factors or the quality of outpatient care. 25 With regard to psychosocial factors, younger women may have less social supports, 9 more anxiety and a higher inclination to stress compared with men, due to an increased work/home burden, 36, 37 thereby impacting their daily functioning and quality of life. Furthermore, an important observation in this study is the greater burden of pre-existing risk factors and co-morbidities in women, including diabetes, chronic heart failure, renal dysfunction, lung disease, cancer, obesity, prior stroke and autoimmune disorders. These findings confirm prior research indicating that young women, but not older women, have more risk factors and co-morbidities at the time of their AMI. 1, 2, 38 Collectively, these observations highlight a need to better understand the outpatient care of young women at risk for an AMI.
In the present study, we found a significant effect of gender in terms of physical limitations, quality of life and physical/mental functioning, even following adjustment for a range of covariates, including depressive symptoms. This finding is an important observation given prior research 9, 39 demonstrating more depressive symptoms in younger women (<60 years) with AMI. Our work not only confirms these prior studies, but raises the possibility that even after adjusting for patients' depressive symptoms there are associated characteristics, such as greater delays in seeking treatment for angina symptoms (i.e. in outpatient care) or perhaps less engagement with health care systems and/or access to prevention strategies, which warrant further evaluation in future studies.
Our findings should be interpreted within the context of several potential limitations. First, this was an observational study and consequently the observed differences between genders in health status outcomes may be due to residual confounding. However, our detailed data collection enabled us to adjust for a broad range of patient-level factors that are typically not included in gender-based research. Second, although we inquired about prior health, patients were interviewed during their index hospitalization for AMI (i.e. health status measures have a 4 week recall period). As such, there is a possibility for poor recall and report bias. Third, it is possible that only healthier patients agreed to participate in this study, which may have impacted on the results (i.e. patients had to survive to consent); however, the long-term objectives of VIRGO are to better illuminate the recovery after AMI and this is not a relevant question in those who die early in their hospitalization. Finally, we only focused on health status outcomes for all three measures at 1 time point (i.e. baseline) and future examination of the long-term health status of these young AMI patients is needed. Importantly, these findings may underscore the importance of measuring pre-event health status at the time of admission to be able to adjust for these differences when looking at longer-term outcomes.
Conclusion
In conclusion, this study has demonstrated that, even after adjusting for important clinical confounders, young women have poorer pre-event physical limitations and quality of life as well as poorer physical and mental functioning, in comparison to similarly aged men. These associations existed, regardless of whether or not patients had known CAD prior to their AMI. These results indicate the potential in targeting the pre-event setting in order to identify highrisk women early. This information may necessitate public health policies, which specifically address risk factors and education in this young female group. 
